BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 31203679)

  • 21. [Updated AWMF Guideline on the Diagnosis and Treatment of Langerhans cell Histiocytosis in Children and Adolescents].
    Lehrnbecher T; Ahlmann M; Albert M; Barnbrock AE; Beutel K; Bochennek K; Classen CF; Holzhauer S; Hutter C; Lakatos K; Meisel R; Porto L; Vokuhl C; Vraetz T; Minkov M
    Klin Padiatr; 2023 Nov; 235(6):322-330. PubMed ID: 37666270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The plasma-soluble CSF1R level is a promising prognostic indicator for pediatric Langerhans cell histiocytosis.
    Zhu T; Wang CJ; Lian HY; Ma HH; Wang D; Wang TY; Zhang R; Cui L; Li ZG
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30970. PubMed ID: 38556751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Placenta in Congenital Langerhans Cell Histiocytosis: A Case Report of Unusual Involvement of Chorionic Plate and Umbilical Vein.
    Ahmad M; Warren LA; Naumaan A; Schatz-Siemers N
    Pediatr Dev Pathol; 2023; 26(5):482-485. PubMed ID: 37334791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Landscape and Its Prognostic Impact in Children With Langerhans Cell Histiocytosis.
    Wang CJ; Cui L; Li SS; Ma HH; Wang D; Lian HY; Zhao YZ; Zhang LP; Li WJ; Zhang Q; Zhao XX; Yang Y; Huang XT; Liu W; Wang YZ; Wu WS; Wang TY; Zhang R; Li ZG
    Arch Pathol Lab Med; 2024 May; ():. PubMed ID: 38749502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features, genomic profiling, and outcomes of adult patients with unifocal Langerhans cell histiocytosis.
    Lang M; Cai HC; Lin H; Chang L; Dai JW; Chen J; Duan MH; Zhou DB; Goyal G; Cao XX
    Orphanet J Rare Dis; 2023 Nov; 18(1):372. PubMed ID: 38037140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vemurafenib combined with chemotherapy achieved sustained remission in pediatric LCH: a multi-center observational study.
    Lei J; Wang W; Lin D; Zhu C; Jia W; Weng W; Liu X; Ma Y; Wang Z; Yang L; He X; He Y; Li Y
    J Cancer Res Clin Oncol; 2024 Jan; 150(1):12. PubMed ID: 38231288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH.
    Evseev D; Osipova D; Kalinina I; Raykina E; Ignatova A; Lyudovskikh E; Baidildina D; Popov A; Zhogov V; Semchenkova A; Litvin E; Kotskaya N; Cherniak E; Voronin K; Burtsev E; Bronin G; Vlasova I; Purbueva B; Fink O; Pristanskova E; Dzhukaeva I; Erega E; Novichkova G; Maschan A; Maschan M
    Blood Adv; 2023 Sep; 7(18):5246-5257. PubMed ID: 37216396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRAF mutations and concurrent alterations in patients with soft tissue sarcoma.
    Kobayashi H; Zhang L; Okajima K; Ishibashi Y; Hirai T; Tsuda Y; Ikegami M; Kage H; Shinozaki-Ushiku A; Oda K; Tanaka S
    Genes Chromosomes Cancer; 2023 Nov; 62(11):648-654. PubMed ID: 37293958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of congenital Langerhans cell histiocytosis with cobimetinib.
    Benjelloun G; Roquet-Gravy C; Marot L; Secco LP; Roquet-Gravy PP; Baeck M; Bulinckx A
    Pediatr Dermatol; 2024; 41(3):515-517. PubMed ID: 38387093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Langerhans cell histiocytosis presenting as a blueberry muffin rash.
    Alanazi SF; Jazzar Y; Beidas T; Soufan H; Mohajer KA; Alhammad A
    Dermatol Reports; 2024 Mar; 16(1):9791. PubMed ID: 38585498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opsin 3 expression in human Langerhans cell histiocytosis and its mediation of ELD-1 cellular function.
    Ye T; Lan Y; Zhang W; Feng J; Luo H; Zeng W; Wang Y; Mou H; Dong X; Zuo L; Lu H
    Eur J Dermatol; 2023 Aug; 33(4):368-382. PubMed ID: 37823488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Langerhans cell histiocytosis mimicking acute dacryocystitis.
    Guàrdia-Ruiz N; López-Miñarro IM; Obregón-Martínez E; Asensio-Sánchez VM
    Arch Soc Esp Oftalmol (Engl Ed); 2024 Jun; ():. PubMed ID: 38901610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosis.
    Karri V; Lin H; Velazquez J; Batajoo A; Parekh D; Stanton W; Abhyankar H; El-Mallawany NK; Agrusa J; Eckstein O; Gulati N; Schwartz J; Woods-Swafford W; Boyd J; Saha A; Allen CE; McClain KL
    Br J Haematol; 2024 May; 204(5):1882-1887. PubMed ID: 38501390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lineage switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis.
    Milne P; Bomken S; Slater O; Kumar A; Nelson A; Roy S; Velazquez J; Mankad K; Nicholson J; Yeomanson D; Grundy R; Kamal A; Penn A; Pears J; Millen G; Morland B; Hayden J; Lam J; Madkhali M; MacDonald J; Singh P; Pagan S; Rodriguez-Galindo C; Minkov M; Donadieu J; Picarsic J; Allen C; Bigley V; Collin M
    Blood Adv; 2023 May; 7(10):2171-2176. PubMed ID: 36112425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRAF
    Sconocchia T; Foßelteder J; Auinger L; Özkaya E; Benezeder T; Lang M; Beham-Schmid C; Hoefler G; Zebisch A; Wölfler A; Sill H; Wolf P; Strobl H; Reinisch A
    Leukemia; 2023 Nov; 37(11):2292-2296. PubMed ID: 37673974
    [No Abstract]   [Full Text] [Related]  

  • 36. Spontaneous remission of skull Langerhans cell histiocytosis that had developed by repeated head injury: illustrative case.
    Ueno K; Katayama K; Mizukami A; Nomura Y; Watanabe R; Sasaki T; Kinoshita S; Fujiwara N; Kakuta K; Morita T; Kamio T; Kudo K; Asano K; Terui K; Kurose A; Saito A
    J Neurosurg Case Lessons; 2023 Aug; 6(8):. PubMed ID: 37728298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The coming of age of Langerhans cell histiocytosis.
    Allen CE; Beverley PCL; Collin M; Diamond EL; Egeler RM; Ginhoux F; Glass C; Minkov M; Rollins BJ; van Halteren A
    Nat Immunol; 2020 Jan; 21(1):1-7. PubMed ID: 31831887
    [No Abstract]   [Full Text] [Related]  

  • 38. A rare diagnosis of Langerhans cell histiocytosis made on thyroid histology with coexisting papillary thyroid cancer and AVP deficiency.
    Dharmaputra RK; Piesse CM; Chaubey S; Sinha AK; Chiam HC
    Endocrinol Diabetes Metab Case Rep; 2024 Apr; 2024(2):. PubMed ID: 38657650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurodegeneration in patients with multisystem Langerhans cell histiocytosis treated with vemurafenib.
    Trambusti I; Pegoraro F; Gaspari S; Dell'Acqua F; Cellini M; Trizzino A; Tondo A; Perrone A; Coniglio ML; Guerrini R; Barba C; Sieni E
    Br J Haematol; 2024 Jun; 204(6):2508-2511. PubMed ID: 38665038
    [No Abstract]   [Full Text] [Related]  

  • 40. Circulating senescent myeloid cells drive blood brain barrier breakdown and neurodegeneration.
    Wilk CM; Cathomas F; Török O; Le Berichel J; Park MD; Heaton GR; Hamon P; Troncoso L; Scull BP; Dangoor D; Silvin A; Fleischmann R; Belabed M; Lin H; Taouli EM; Boettcher S; Manz MG; Kofler JK; Yue Z; Lira SA; Ginhoux F; Crary JF; McClain KL; Picarsic JL; Russo SJ; Allen CE; Merad M
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.